A post-departure stock bump and no succession plan

A post-departure stock bump and no succession plan

Pat Gelsinger’s plight at Intel might be a warning for boomerang executives: Even when a company wins you back and appoints you CEO, the honeymoon can end in a flash. Intel’s board of directors announced Gelsinger’s retirement as chief executive, effective yesterday, today. The company didn’t name a successor and instead appointed two executives as…

Read More
China investigation of drug firm exec deals latest blow to foreign business confidence

China investigation of drug firm exec deals latest blow to foreign business confidence

An investigation of a top China executive from British-Swedish company AstraZeneca – and the lack of transparency surrounding the case – is set to deal another blow to foreign business confidence in the country, according to observers. AstraZeneca, the largest foreign pharmaceutical company in China, said on Wednesday that its China president, Leon Wang, was…

Read More